Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

npj Vaccines (2)
Nature Medicine (2)
Molecular Psychiatry (1)
Nature (1)
Scientific Reports (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (7)
Correspondence (1)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Diseases
Drug discovery
Immunology
Medical research
Neurology
Neuroscience
Scientific community
Signs and symptoms

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Maxime Taquet Clear advanced filters

Reply to: Methodological Issues in Taquet et al.'s analysis preclude any conclusions regarding AS01 adjuvant's specific role in dementia prevention

Maxime Taquet
John A. Todd
Paul J. Harrison
ResearchOpen Access08 Dec 2025
npj Vaccines

Volume: 10, P: 1-2
Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization

Longitudinal proteomic profiling of over 1,800 patients revealed two distinct profiles of blood biomarkers measured on admission to hospital for COVID-19, which predict cognitive deficits 6 and 12 months later.

Maxime Taquet
Zuzanna Skorniewska
Paul J. Harrison
ResearchOpen Access31 Aug 2023
Nature Medicine

Volume: 29, P: 2498-2508
Anonymity takes more than protecting personal details

Yves-Alexandre de Montjoye
Maxime Taquet
Correspondence08 Oct 2019
Nature

Volume: 574, P: 176
The recombinant shingles vaccine is associated with lower risk of dementia

A natural experiment including more than 200,000 people who received a shingles vaccine reveals that, within 6 years of vaccination, the recombinant vaccine is associated with lower risk of dementia than is the live vaccine.

Maxime Taquet
Quentin Dercon
Paul J. Harrison
ResearchOpen Access25 Jul 2024
Nature Medicine

Volume: 30, P: 2777-2781
Extra-axonal restricted diffusion as an in-vivo marker of reactive microglia

Maxime Taquet
Aleksandar Jankovski
Benoît Scherrer
ResearchOpen Access25 Sept 2019
Scientific Reports

Volume: 9, P: 1-10
Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections

Maxime Taquet
John A. Todd
Paul J. Harrison
ResearchOpen Access25 Jun 2025
npj Vaccines

Volume: 10, P: 1-6
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders

De Giorgi and colleagues present a comprehensive analysis of pre-clinical and clinical studies examining the role of glucagon-like peptide-1 receptor agonists in mental disorders.

Riccardo De Giorgi
Ana Ghenciulescu
Catherine J. Harmer
ResearchOpen Access13 Feb 2025
Nature Mental Health

Volume: 3, P: 354-373
A structural brain network of genetic vulnerability to psychiatric illness

Maxime Taquet
Stephen M. Smith
Paul J. Harrison
ResearchOpen Access06 May 2020
Molecular Psychiatry

Volume: 26, P: 2089-2100